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ABSTRACT
â€œComparison of the effectiveness of the combination therapy of ondansetrone-dexamethasone 
to granisetrone-dexamethasone in the preventing of acute nausea - vomiting due to TAC 
regimen of chemotherapy in breast cancer patientsâ€•
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Background.  
The American  Cancer Society estimates that in 2013 , there were 14 % of all cancer deaths caused 
by breast cancer . TAC regimen of chemotherapy is one of treatment modality of breast cancer , and 
has a high emetic potential. Ondansetron and granisetron plays an important role in the prevention of 
acute nausea and vomiting due to chemotherapy. Ondansetron as an effective single dose in 32mg 
doses, while effective at a dose of 1mg granisetron.
Purpose. 
To  obtain  a  comparison  between  the  effectiveness  of  the  combination  therapy  of  ondansetronedexamethasone to
granisetrone â€“ dexamethasone in the preventing of acute nausea -  vomiting due to 
TAC regimen of chemotherapy in breast cancer patients.
Patients and Methods. 
This  study  is  a  clinical  trial  with  single-blind  and  cross-over  design  ,  the  first  group  received 
ondansetron  32mg  and  dexamethasone  20mg  on  the  first  cycle  and  then  got  granisetron  1mg  and 
dexamethasone 20 mg on the second cycle or vice versa in the second group . This research was 
conducted at  Dr.Zainoel  Abidinâ€™s    Hospital from June to August 2013 . All subjects performed an 
assessment  of  the  quality  of  nausea  ,  vomiting  frequency  ,  therapeutic  response  and  side  effects 
within the first 24 hours of chemotherapy.
Results. 
There  was  no  significant  difference  in  the  degree  of  nausea  ,  vomiting  and  frequency  response 
between combination therapy with ondansetrone  â€“  dexamethasone to granisetrone-  dexamethasone 
in the prevention of acute nausea and vomiting due to TAC regimen. The most common side effects 
reported were decreased appetite, headache, abdominal discomfort, insomnia and impaired vision. 
Side effects more visual disturbances reported in ondansetron group, p = 0.02.
Conclusion. 
Granisetron  -  dexamethasone  combination  therapy  has  the  same  effectiveness  with  ondansetron  -dexamethasone , both well
tolerated , although side effects were reported more visual impairment in 
the ondansetron group.
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